Search results
Roche Holding AG ADR
WKN: 891106 / Symbol: RHHBY / Name: Roche / Stock / Pharmaceuticals / Large Cap /
€28.28
0.440%
Resurs Holding AB
WKN: A2AHSD / Name: Resurs Holding AB / Stock / Banking Services / Small Cap /
€1.22
-7.460%
Ezion Holdings
Name: Ezion Holdings / Stock / Oil & Gas Related Equipment and Services / Small Cap /
-
-
Scholar Rock Holding
WKN: A2JMQW / Symbol: SRRK / Name: Scholar Rock / Stock / Small Cap /
€13.60
5.380%
[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-Produkte
- Konzernverkäufe stiegen um 2%1 zu konstanten Wechselkursen (CER; -6% in CHF) dank starkem Wachstum der jüngeren Medikamente und Diagnostika; ohne COVID-19-Produkte nahmen die Konzernverkäufe um 7%
Antibodies Market Surge: Anticipated 3X Growth by 2032
Key trends and prospects in terms of product type, application, and end user for the next ten years are provided by Fact.MR in their most recent Antobodies Market research. The study also focuses
Expanding Horizons: Transfection Technologies Market's 7.5% CAGR Forecast
According to a recent industry report by market research and competitive intelligence source Fact.MR, the global Transfection Technologies Market is expected to reach US$ 2.27 billion by the end